8 February 2018 A quaternary ammonium modified coumarin derivative for antimicrobial photodynamic therapy
Author Affiliations +
Abstract
A new cationic modified coumarin derivative, 7-diethylamino-3-(3-(4-(trimethylbenzenaminium iodide) phenyl) acryloyl)-2H-chromen-2-one (1), was synthesized and characterized by 1H NMR and mass spectra. It had a strong intramolecular charge transfer absorption band around 460 nm with large molar extinction coefficients of 3.94 × 104 M-1 cm-1 in DMF and 3.86 × 104 M-1 cm-1 in PBS, respectively. Moreover, a moderate singlet oxygen quantum yield of 0.16 was obtained for 1 in DMF. Using methylene blue (MB) under a 630 nm laser as reference, the in vitro antimicrobial photodynamic therapy (aPDT) activity of 1 against three strains, gram positive bacteria methicillin-resistant staphylococcus aureus (MRSA), negative bacteria acinetobacter baumannii (A. baumannii) and fungus Candida albicans (C. albicans), was carried out by irradiation with a 457 nm laser. It was shown that 1 had no dark toxicity to these bacteria when its concentration was up to 100 μM, while under the 457 nm laser it could kill them effectively with an over 3 log CFU/ml decrease of the bacterial viability with its concentration up to 5 μM. The aPDT capability of 1 against MRSA and A. baumannii was equivalent to that of MB. For C. albicans, 1 exhibited much better aPDT effect than MB.
© (2018) COPYRIGHT Society of Photo-Optical Instrumentation Engineers (SPIE). Downloading of the abstract is permitted for personal use only.
Zhiyuan Sun, Zhiyuan Sun, Shaona Zhou, Shaona Zhou, Ying Gu, Ying Gu, Yuxia Zhao, Yuxia Zhao, } "A quaternary ammonium modified coumarin derivative for antimicrobial photodynamic therapy", Proc. SPIE 10479, Light-Based Diagnosis and Treatment of Infectious Diseases, 104790Z (8 February 2018); doi: 10.1117/12.2287086; https://doi.org/10.1117/12.2287086
PROCEEDINGS
8 PAGES


SHARE
Back to Top